Ordeniza, Maximo M.

HRN: 16-78-51  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
CEFTRIAXONE 1G (VIAL)
04/06/2026
04/12/2026
IV
2g
OD
Cap-mr; T/c Ptb Relapse
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: